CBS 2019
CBSMD教育中心
中 文

科学研究

Abstract

Recommended Article

Ticagrelor versus clopidogrel in patients with acute coronary syndromes Early Rhythm-Control Therapy in Patients with Atrial Fibrillation Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance Left Ventricular Hypertrophy and Clinical Outcomes Over 5 Years After TAVR: An Analysis of the PARTNER Trials and Registries Current treatment of significant left main coronary artery disease: A review The Year in Cardiovascular Medicine 2020: Coronary Prevention: Looking back on the Year in Cardiovascular Medicine for 2020 in the field of coronary prevention is Professor Ramon Estruch, Dr Luis Ruilope, and Professor Francesco Cosentino. Mark Nicholls meets them Two-year outcomes following unprotected left main stenting with first vs new-generation drug-eluting stents: the FINE registry. EuroIntervention. Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial

Guideline26 August 2017

JOURNAL:European Heart Journal Article Link

2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries Endorsed

V. Aboyans, J-B Ricco, M-L E. L. Bartelink et al. Keywords: Prevention; Peripheral Vascular Intervention; Peripheral Arterial Diseases

Full Text PDF